Literature DB >> 3422104

Renal disease in type I glycogen storage disease.

Y T Chen1, R A Coleman, J I Scheinman, P C Kolbeck, J B Sidbury.   

Abstract

Although kidney enlargement occurs in Type I glycogen storage disease, renal disease has not been considered a major problem. Death from renal failure in three patients known to us prompted a study of renal function in this disorder. Of the 38 patients with Type I glycogen storage disease under our care, the 18 children under 10 years old had normal renal function. Fourteen of the 20 older patients (13 to 47 years) had disturbed renal function, manifested by persistent proteinuria; many also had hypertension, hematuria, or altered creatinine clearance. Progressive renal insufficiency developed in 6 of these 14 patients, leading to three deaths from renal failure. At the onset of proteinuria, creatinine clearance was increased in seven patients (3.05 +/- 0.68 ml per second per 1.73 m2 of body-surface area; range, 2.47 to 4.13 [normal range, 1.33 to 2.33 ml per second per 1.73 m2]). Renal biopsies were performed in three patients after an average of 10 years of proteinuria. All three biopsies demonstrated focal segmental glomerulosclerosis in various stages of progression. Our data suggest that chronic renal disease is a frequent and potentially serious complication of Type I glycogen storage disease. In addition to treating hypoglycemia vigorously, physicians should monitor renal function carefully in patients with this disorder.

Entities:  

Mesh:

Year:  1988        PMID: 3422104     DOI: 10.1056/NEJM198801073180102

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

1.  Variability of renal length in type I glycogen storage disease.

Authors:  Y T Chen; K A Feinstein; R A Coleman; E L Effmann
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Renal function and kidney size in glycogen storage disease type I.

Authors:  W C Reitsma-Bierens; G P Smit; J A Troelstra
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

3.  In search of proof-of-concept: gene therapy for glycogen storage disease type Ia.

Authors:  Dwight D Koeberl
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

Review 4.  Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  Nat Rev Endocrinol       Date:  2010-10-26       Impact factor: 43.330

5.  Tight metabolic control plus ACE inhibitor therapy improves GSD I nephropathy.

Authors:  Gyongyi O Okechuku; Lawrence R Shoemaker; Monika Dambska; Laurie M Brown; Justin Mathew; David A Weinstein
Journal:  J Inherit Metab Dis       Date:  2017-06-13       Impact factor: 4.982

Review 6.  Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease.

Authors:  Janice Y Chou; Brian C Mansfield
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

7.  Echogenic kidneys and medullary calcium deposition in a young child with glycogen storage disease type 1a.

Authors:  J J Fick; F J Beek
Journal:  Pediatr Radiol       Date:  1992

8.  Urinary lactate excretion in type 1 glycogenosis--a marker of metabolic control or renal tubular dysfunction?

Authors:  P J Lee; C Chatterton; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 9.  Proteinuria in a child with sialidosis: case report and histological studies.

Authors:  C E Kashtan; T E Nevins; Z Posalaky; R L Vernier; A J Fish
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

10.  Effective renal plasma flow in patients with glycogen storage disease type I.

Authors:  H Hahn-Ullrich; J Sciuk; P Bartenstein; P Kreysing; K Ullrich
Journal:  Eur J Pediatr       Date:  1993-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.